Author: Lew, Qiao Jing; Chu, Kai Ling; Lee, Jialing; Koh, Poh Ling; Rajasegaran, Vikneswari; Teo, Jin Yuan; Chao, Sheng-Hao
Title: PCAF interacts with XBP-1S and mediates XBP-1S-dependent transcription Document date: 2010_9_4
ID: 174q2pjw_38
Snippet: The tumor microenvironment is hypoglycemic and hypoxic, resulting in induction of UPR and overexpression of XBP-1. Recent studies show the involvement of XBP-1 in tumorigenesis of various cancers and suggest XBP-1 as a potential target for anti-cancer therapeutics (10) (11) (12) 43) . Fujimoto et al. investigated the expression of XBP-1 in 11 primary breast cancers and five breast cancer cell lines, including MCF7. The increased expression of XBP.....
Document: The tumor microenvironment is hypoglycemic and hypoxic, resulting in induction of UPR and overexpression of XBP-1. Recent studies show the involvement of XBP-1 in tumorigenesis of various cancers and suggest XBP-1 as a potential target for anti-cancer therapeutics (10) (11) (12) 43) . Fujimoto et al. investigated the expression of XBP-1 in 11 primary breast cancers and five breast cancer cell lines, including MCF7. The increased expression of XBP-1 was detected in all breast cancers and cell lines examined, but not in the non-cancerous breast issue (44) . In addition, clinical results showed that high levels of XBP-1S increased the survival of breast cancers (45) . Our data presented here demonstrate the functional importance of PCAF in mediating the expression of XBP-1S target genes in MCF7 cells (Figures 6 and 7) , suggesting a potential role of PCAF in XBP-1S-mediated tumerigenesis of breast cancers. Furthermore, PCAF may be an essential factor for other XBP-1S-mediated signaling pathways. For example, XBP-1S is one of the key components in the transcriptional program controlling plasma cell differentiation (1) . It would be worthwhile to examine the importance of PCAF-XBP-1S during the development of plasma cells.
Search related documents:
Co phrase search for related documents- anti cancer therapeutic and essential factor: 1
- anti cancer therapeutic and potential target: 1
- breast cancer and cancer cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41
- breast cancer and cancer tumorigenesis: 1, 2
- breast cancer and cell line: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58
- breast cancer and cell line breast cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- breast cancer and clinical result: 1, 2, 3
- breast cancer and expression investigate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- breast cancer and high level: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- breast cancer and increase expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- breast cancer and key component: 1, 2
- breast cancer and pathway signaling: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- breast cancer and plasma cell: 1, 2, 3, 4, 5
- breast cancer and potential role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- breast cancer and potential target: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- breast cancer and primary breast cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- breast cancer and recent study: 1, 2, 3, 4, 5, 6, 7, 8, 9
- breast cancer and target gene: 1, 2, 3, 4, 5, 6, 7, 8, 9
- breast cancer and transcriptional program: 1
Co phrase search for related documents, hyperlinks ordered by date